Equity (Tables)

3 Months Ended

Mar. 31, 2018

Equity [Abstract]

Schedule of Common Stock Granted

During the three months ended March 31, 2018 and 2017, the Company granted common shares to certain employees as follows:

	Three Months ended March 31,
	2018	2017
Performance Shares(1)
Shares granted:
Index - 1Q	331,025	106,706
Peer - 1Q	331,019	106,705
Grant date fair value per share:(2)
Index - 1Q	$5.81	$6.82
Peer - 1Q	$5.37	$6.34
Non-Vested Common Shares:(3)
Shares issued	237,570	237,560
Grant date fair value	$2,190	$2,551

(1) The shares vest based on the Company's total shareholder return growth after a three-year measurement period relative to an index and a group of Company peers. Dividends will not be paid on these grants until earned. Once the performance criteria are met and the actual number of shares earned is determined, such shares vest immediately. During the three months ended March 31, 2018, 116,926 of the 642,029 performance shares issued in 2015 vested.

(2) The fair value of grants was determined at the grant date using a Monte Carlo simulation model.

(3) The shares vest ratably over a three-year service period.

Schedule of Accumulated Other Comprehensive Income (Loss)

A summary of the changes in accumulated other comprehensive income (loss) related to the Company's cash flow hedges is as follows:

	Three Months ended March 31,
	2018			2017
Balance at beginning of period	$	1,065		$	(1,033	)
Other comprehensive income before reclassifications	494			688
Amounts of (income) loss reclassified from accumulated other comprehensive income (loss) to interest expense	(248		)	604
Balance at end of period	$	1,311		$	259